{"id":44185,"date":"2022-05-20T18:01:14","date_gmt":"2022-05-20T16:01:14","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/"},"modified":"2022-05-20T18:01:14","modified_gmt":"2022-05-20T16:01:14","slug":"united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/","title":{"rendered":"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5337778\/anxiety-drugs-market-research-report-by-type?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=j5nsxd&amp;utm_campaign=1702974+-+United+States+Anxiety+Drugs+(Generic+and+Patent+Medicine)+Market+Research+Report+2022-2027&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Anxiety Drugs Market Research Report by Type (Generic Drugs and Patent Medicine), Application, State &#8211; United States Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe United States Anxiety Drugs Market size was estimated at USD 3,023.13 million in 2021, USD 3,448.71 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.51% to reach USD 5,508.14 million by 2027.\n<\/p>\n<p>\nIn this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.\n<\/p>\n<p>\n<strong>Cumulative Impact of COVID-19:<\/strong>\n<\/p>\n<p>\nThe report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.\n<\/p>\n<p>\n<strong>Competitive Strategic Window:<\/strong>\n<\/p>\n<p>\nThe Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.\n<\/p>\n<p>\nIt describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research &amp; development, and new product introduction strategies to execute further business expansion and growth during a forecast period.\n<\/p>\n<p>\n<strong>FPNV Positioning Matrix:<\/strong>\n<\/p>\n<p>\nThe FPNV Positioning Matrix evaluates and categorizes the vendors in the Anxiety Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.\n<\/p>\n<p>\n<strong>Market Share Analysis:<\/strong>\n<\/p>\n<p>\nThe Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others.\n<\/p>\n<p>\nKnowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.\n<\/p>\n<p>\n<strong>Company Usability Profiles:<\/strong>\n<\/p>\n<ul>\n<li>\nAllergan plc.\n<\/li>\n<li>\nAPOTEX\n<\/li>\n<li>\nAstraZeneca plc.\n<\/li>\n<li>\nEli Lilly And Company\n<\/li>\n<li>\nGlaxoSmithKline plc.\n<\/li>\n<li>\nGsk\n<\/li>\n<li>\nH. Lundbeck A\/S\n<\/li>\n<li>\nHuahai Pharmaceutical\n<\/li>\n<li>\nJIANFENG Pharmaceutical\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nKanghong Pharmaceutical\n<\/li>\n<li>\nMerck &amp; Co. Inc.\n<\/li>\n<li>\nMylan\n<\/li>\n<li>\nOtsuka Pharmaceutical Co., Ltd.\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nSun Pharmaceuticals Pvt Ltd.\n<\/li>\n<li>\nTakeda Pharmaceutical Company Ltd.\n<\/li>\n<li>\nValeant Pharmaceuticals\n<\/li>\n<li>\nWin Sunny\n<\/li>\n<li>\nZydus Pharmaceutical\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Preface<\/strong>\n<\/p>\n<p>\n1.1. Objectives of the Study\n<\/p>\n<p>\n1.2. Market Segmentation &amp; Coverage\n<\/p>\n<p>\n1.3. Years Considered for the Study\n<\/p>\n<p>\n1.4. Currency &amp; Pricing\n<\/p>\n<p>\n1.5. Language\n<\/p>\n<p>\n1.6. Limitations\n<\/p>\n<p>\n1.7. Assumptions\n<\/p>\n<p>\n1.8. Stakeholders\n<\/p>\n<p>\n<strong>2. Research Methodology<\/strong>\n<\/p>\n<p>\n2.1. Define: Research Objective\n<\/p>\n<p>\n2.2. Determine: Research Design\n<\/p>\n<p>\n2.3. Prepare: Research Instrument\n<\/p>\n<p>\n2.4. Collect: Data Source\n<\/p>\n<p>\n2.5. Analyze: Data Interpretation\n<\/p>\n<p>\n2.6. Formulate: Data Verification\n<\/p>\n<p>\n2.7. Publish: Research Report\n<\/p>\n<p>\n2.8. Repeat: Report Update\n<\/p>\n<p>\n<strong>3. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4. Market Overview<\/strong>\n<\/p>\n<p>\n<strong>5. Market Insights<\/strong>\n<\/p>\n<p>\n5.1. Market Dynamics\n<\/p>\n<p>\n5.1.1. Drivers\n<\/p>\n<p>\n5.1.2. Restraints\n<\/p>\n<p>\n5.1.3. Opportunities\n<\/p>\n<p>\n5.1.4. Challenges\n<\/p>\n<p>\n5.2. Cumulative Impact of COVID-19\n<\/p>\n<p>\n<strong>6. Anxiety Drugs Market, by Type<\/strong>\n<\/p>\n<p>\n6.1. Introduction\n<\/p>\n<p>\n6.2. Generic Drugs\n<\/p>\n<p>\n6.3. Patent Medicine\n<\/p>\n<p>\n<strong>7. Anxiety Drugs Market, by Application<\/strong>\n<\/p>\n<p>\n7.1. Introduction\n<\/p>\n<p>\n7.2. Help Sleep\n<\/p>\n<p>\n7.3. Treat anxiety\n<\/p>\n<p>\n7.4. Treat Premature Ejaculation\n<\/p>\n<p>\n<strong>8. California Anxiety Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>9. Florida Anxiety Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>10. Illinois Anxiety Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>11. New York Anxiety Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>12. Ohio Anxiety Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>13. Pennsylvania Anxiety Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>14. Texas Anxiety Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>15. Competitive Landscape<\/strong>\n<\/p>\n<p>\n15.1. FPNV Positioning Matrix\n<\/p>\n<p>\n15.1.1. Quadrants\n<\/p>\n<p>\n15.1.2. Business Strategy\n<\/p>\n<p>\n15.1.3. Product Satisfaction\n<\/p>\n<p>\n15.2. Market Ranking Analysis\n<\/p>\n<p>\n15.3. Market Share Analysis, By Key Player\n<\/p>\n<p>\n15.4. Competitive Scenario\n<\/p>\n<p>\n15.4.1. Merger &amp; Acquisition\n<\/p>\n<p>\n15.4.2. Agreement, Collaboration, &amp; Partnership\n<\/p>\n<p>\n15.4.3. New Product Launch &amp; Enhancement\n<\/p>\n<p>\n15.4.4. Investment &amp; Funding\n<\/p>\n<p>\n15.4.5. Award, Recognition, &amp; Expansion\n<\/p>\n<p>\n<strong>16. Company Usability Profiles<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5337778\/anxiety-drugs-market-research-report-by-type?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=j5nsxd&amp;utm_campaign=1702974+-+United+States+Anxiety+Drugs+(Generic+and+Patent+Medicine)+Market+Research+Report+2022-2027&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/5815&#215;8<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#58;pr&#x65;&#x73;&#115;&#64;&#x72;&#x65;&#115;&#101;a&#x72;&#x63;&#104;a&#x6e;&#x64;&#109;&#97;r&#x6b;&#x65;&#116;s&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;e&#x73;&#x73;&#64;r&#x65;&#x73;&#101;a&#x72;&#x63;&#104;a&#x6e;&#x64;&#109;a&#x72;&#107;&#101;t&#x73;&#46;c&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Anxiety Drugs Market Research Report by Type (Generic Drugs and Patent Medicine), Application, State &#8211; United States Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The United States Anxiety Drugs Market size was estimated at USD 3,023.13 million in 2021, USD 3,448.71 million in 2022, and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-44185","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Anxiety Drugs Market Research Report by Type (Generic Drugs and Patent Medicine), Application, State &#8211; United States Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The United States Anxiety Drugs Market size was estimated at USD 3,023.13 million in 2021, USD 3,448.71 million in 2022, and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-20T16:01:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-05-20T16:01:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/\"},\"wordCount\":651,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005334\\\/en\\\/1462715\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/\",\"name\":\"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005334\\\/en\\\/1462715\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-05-20T16:01:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005334\\\/en\\\/1462715\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220520005334\\\/en\\\/1462715\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Anxiety Drugs Market Research Report by Type (Generic Drugs and Patent Medicine), Application, State &#8211; United States Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The United States Anxiety Drugs Market size was estimated at USD 3,023.13 million in 2021, USD 3,448.71 million in 2022, and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-20T16:01:14+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 &#8211; ResearchAndMarkets.com","datePublished":"2022-05-20T16:01:14+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/"},"wordCount":651,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/","name":"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/21\/logo.jpg","datePublished":"2022-05-20T16:01:14+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220520005334\/en\/1462715\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/united-states-anxiety-drugs-generic-and-patent-medicine-market-research-report-2022-2027-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44185"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44185\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}